Replies

You criticize Big Pharma but do you consider the huge cost of research and development, testing and production for something like Pfizer’s mRNA vaccine for COVID-19? The money does not come out of thin air. They don’t just mash up some Chinese tree bark and make an injection from it. After the meticulous makeup that messenger RNA has to be kept at minus 74 degrees Fahrenheit because of the unstable nature of the RNA blueprint. That takes a lot of money to come up with that technology. That money does not come out of thin air. It comes out of the sum total of the successful application that saves human life enough that people pay money for it. What? Do you want Pfizer and Moderna to lose money on it?

If you want alternative treatments for COVID-19 (DELTA) why don’t you organize a team to raise the money for the research and development, the testing and production and distribution? If you say that ivermectin has already been created and has passed the trials and has FDA approval, there is one problem. They do not know if the necessary dose to treat COVID is safe for humans and will be effective. Clinical trials have to be done to learn the answer to many questions. If the trials do not show ivermectin is safe at the necessary dose, then out goes that remedy after much expense.

The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Pivotal (phase 3) studies for new drugs approved by the Food and Drug Administration (FDA) cost a median of $41,117 per patient. Who is willing to take a chance on ivermectin for COVID?

You criticize Big Pharma but do you consider the huge cost of research and development, testing and production for something like Pfizer’s mRNA vaccine for COVID-19? The money does not come out of thin air.

I am fully aware of this massive cost, and I know full well only a small percent of those $$ even make it past initial research, much less make it to animal trials, much less make it to human trials, much less even get approved. And yet, for these "vaccines", the money DID come out of thin air - FedGov just threw billions of $$ at these companies, and I'm sure plenty ended up in your other guy's offshore bank accounts.

What? Do you want Pfizer and Moderna to lose money on it?You bet I do, when the cost to me and the rest of the country for them to 'make money' is a complete disregard for other, more effective and much cheaper treatments, a massive destruction of private liberties, a huge increase in national debt that FegGov has no Constitutional power to expend, and so on. Their profit comes at a much greater expense.

If you say that ivermectin has already been created and has passed the trials and has FDA approval, there is one problem. They do not know if the necessary dose to treat COVID is safe for humans and will be effective. Clinical trials have to be done to learn the answer to many questions. If the trials do not show ivermectin is safe at the necessary dose, then out goes that remedy after much expense.

Once again, testing effective dosages for an already known off-label is much less work and expense than a new drug that has to INCLUDE THAT SAME STEP, as well as 100s of others. Your new drugs have the same problem, only more so, you claim [ivermectin] has - no one knows what the effective dosaging is, but in addition no one knows what the max safe dose, toxic dose, etc is. No one knows ANYTHING about them - all of that still needs additional testing besides just effective dose.

The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Pivotal (phase 3) studies for new drugs approved by the Food and Drug Administration (FDA) cost a median of $41,117 per patient. Who is willing to take a chance on ivermectin for COVID?

So about $40MM to completely test a potential treatment, which equals about 1000 test subjects for your new drug. That doesn't sound close to a sufficient clinical trial pool to get a drug approved. Sounds like the financial incentives lean extremely heavily to utilizing existing treatments instead of developing new ones, ESPECIALLY new ones that are an entirely new type of drug. And apparently a lot of people are willing to try out Ivermectiin, take a look at Japan and several other countries!